Vedanta Biosciences' Series A Round

Vedanta Biosciences raised a round of funding on June 06, 2016.

Vedanta Biosciences has built a proprietary platform for the discovery, development, and manufacturing of drugs based on live commensal microbes. Using Vedanta's platform, the company has isolated a v…

Articles about Vedanta Biosciences' Series A Round: